Key result
AI enhances fetal imaging and detects congenital heart disease with up to ~95% accuracy.
Why the study?
Although artificial intelligence has advanced automated image enhancement, segmentation, and abnormal feature detection in fetal echocardiography and MRI for prenatal CHD diagnosis, challenges remain regarding data quality, algorithm complexity, computational demands, clinical acceptance, and workflow integration.
Does the integration of artificial intelligence with fetal echocardiography and fetal MRI improve the prenatal detection and diagnostic accuracy of congenital heart disease in fetuses?
Does the integration of artificial intelligence with fetal echocardiography and fetal MRI improve the prenatal detection and diagnostic accuracy of congenital heart disease in fetuses?
This narrative review highlights that integrating deep learning and machine learning with fetal echocardiography and MRI significantly improves image quality, automated segmentation, and diagnostic accuracy for prenatal congenital heart disease detection, though prospective multicenter validation is needed before widespread clinical adoption.
Answers are grounded in this paper and cite their sources.
May enhance prenatal CHD detection; leaves open prospective multicenter validation before clinical adoption.
Detection and diagnosis of congenital heart disease during fetal echocardiography and magnetic resonance imaging are other areas that artificial intelligence has transformed the prenatal healthcare system. This review discusses the application of AI in these imaging approaches with regard to the progress achieved in automated image enhancement and segmentation, as well as the detection of abnormal features. Advanced AI models, especially the deep learning algorithms, have demonstrated encouraging outcomes in terms of diagnostic accuracy, human error reduction, and quicker decisions. In spite of these developments, some challenges have been left, such as data quality, complexity of the algorithm, and the fact that large computational resources are required. There are challenges regarding clinical acceptance, regulatory issues, and the integration of AI into existing workflows. Nevertheless, the opportunities of AI, in particular, custom pregnancy care and the availability of more complex diagnostics, are promising. Further advances in the field of multi-modal AI integration, transfer learning, and ongoing enhancement of algorithms should contribute to better AI application in prenatal CHD detection. The advancement of AI technologies has the potential to transform prenatal diagnostics, leading to improved outcomes for both mothers and newborns. The present review emphasizes the need to conduct further research, take ethical factors into account, and establish effective and consistent regulatory frameworks to guarantee successful and fair usage of AI in clinical practice.
No takes yet. Share an insight, caveat, or question.
Shamsi Ghaffari (2026) conducted a review in Fetal congenital heart disease (CHD). Artificial intelligence (machine learning and deep learning) integrated with fetal echocardiography and fetal MRI vs. Conventional operator-dependent fetal echocardiography and MRI interpretation was evaluated on Prenatal detection, image quality enhancement, segmentation, and severity prediction of congenital heart disease. Artificial intelligence integrated with fetal echocardiography and MRI improves image quality, automates segmentation, and achieves high accuracy in prenatal CHD detection.
Synapse has enriched 10 related papers. Consider them for comparative context: